Literature DB >> 20176021

Genetic approaches to functional gastrointestinal disorders.

Yuri A Saito1, Nandita Mitra, Emeran A Mayer.   

Abstract

Functional gastrointestinal disorders are complex symptom-based disorders without agreed upon biomarkers or pathophysiology. A better understanding of the genetic architecture of these disorders would help to better identify their complex biology and explain the common comorbidity with other disorders of persistent pain, mood, and affect, as well as possibly make it possible to identify subgroups of patients who respond to customized therapies. In contrast to monogenic diseases, polygenic diseases and traits are characterized by the contribution of common variants in a large number of genes, as well as environmental factors, to the vulnerability of an individual. Family and twin studies have clearly established a genetic component in irritable bowel syndrome. Although candidate gene studies have identified a few gene polymorphisms that may be correlated with the syndrome, small sample size, lack of reproducibility in large data sets, and the unreliability of the clinical phenotype require caution when extrapolating to a major role of any of the reported polymorphisms in the pathophysiology of irritable bowel syndrome. Future progress in this area will require better characterization of intermediate phenotypes with large effect size for the clinical phenotype, as well as consideration of gene-gene, environment-gene (epigenetics), and sex-gene interactions, genome-wide association, and whole genome sequencing approaches in large data sets. 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20176021      PMCID: PMC3829382          DOI: 10.1053/j.gastro.2010.02.037

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  67 in total

1.  Identifying interacting SNPs using Monte Carlo logic regression.

Authors:  Charles Kooperberg; Ingo Ruczinski
Journal:  Genet Epidemiol       Date:  2005-02       Impact factor: 2.135

2.  A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group.

Authors:  S Bellentani; P Baldoni; S Petrella; C Tata; C Armocida; P Marchegiano; G Saccoccio; F Manenti
Journal:  Fam Pract       Date:  1990-12       Impact factor: 2.267

3.  Epigenetic programming of stress responses through variations in maternal care.

Authors:  Eric W Fish; Dara Shahrokh; Rose Bagot; Christian Caldji; Timothy Bredy; Moshe Szyf; Michael J Meaney
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

4.  A bayesian approach to detect quantitative trait loci using Markov chain Monte Carlo.

Authors:  J M Satagopan; B S Yandell; M A Newton; T C Osborn
Journal:  Genetics       Date:  1996-10       Impact factor: 4.562

5.  Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.

Authors:  Patrick P J van der Veek; Marlies van den Berg; Yvette E de Kroon; Hein W Verspaget; Ad A M Masclee
Journal:  Am J Gastroenterol       Date:  2005-11       Impact factor: 10.864

6.  Genetic basis for individual variations in pain perception and the development of a chronic pain condition.

Authors:  Luda Diatchenko; Gary D Slade; Andrea G Nackley; Konakporn Bhalang; Asgeir Sigurdsson; Inna Belfer; David Goldman; Ke Xu; Svetlana A Shabalina; Dmitry Shagin; Mitchell B Max; Sergei S Makarov; William Maixner
Journal:  Hum Mol Genet       Date:  2004-11-10       Impact factor: 6.150

7.  Female, but not male, serotonin reuptake transporter (5-HTT) knockout mice exhibit bladder instability.

Authors:  L L Cornelissen; D P Brooks; A Wibberley
Journal:  Auton Neurosci       Date:  2005-07-14       Impact factor: 3.145

8.  Non-colonic features of irritable bowel syndrome.

Authors:  P J Whorwell; M McCallum; F H Creed; C T Roberts
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

9.  Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress.

Authors:  Motoyori Kanazawa; Yuka Endo; William E Whitehead; Michiko Kano; Michio Hongo; Shin Fukudo
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

10.  Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women.

Authors:  A Yeo; P Boyd; S Lumsden; T Saunders; A Handley; M Stubbins; A Knaggs; S Asquith; I Taylor; B Bahari; N Crocker; R Rallan; S Varsani; D Montgomery; D H Alpers; G E Dukes; I Purvis; G A Hicks
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

View more
  34 in total

1.  Association of TNFSF15 polymorphism with irritable bowel syndrome.

Authors:  Marco Zucchelli; Michael Camilleri; Anna Nixon Andreasson; Francesca Bresso; Aldona Dlugosz; Jonas Halfvarson; Leif Törkvist; Peter T Schmidt; Pontus Karling; Bodil Ohlsson; Richard H Duerr; Magnus Simren; Greger Lindberg; Lars Agreus; Paula Carlson; Alan R Zinsmeister; Mauro D'Amato
Journal:  Gut       Date:  2011-06-02       Impact factor: 23.059

2.  Analgesic effect of Coptis chinensis rhizomes (Coptidis Rhizoma) extract on rat model of irritable bowel syndrome.

Authors:  Yungwui Tjong; Siupo Ip; Lixing Lao; Harry H S Fong; Joseph J Y Sung; Brian Berman; Chuntao Che
Journal:  J Ethnopharmacol       Date:  2011-04-12       Impact factor: 4.360

Review 3.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

Authors:  Michael Camilleri; David A Katzka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

4.  Overcoming obstacles to developing new analgesics.

Authors:  Clifford J Woolf
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

5.  Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis.

Authors:  M Camilleri; P Carlson; S McKinzie; M Zucchelli; M D'Amato; I Busciglio; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2011-07-14       Impact factor: 3.598

6.  Functional abdominal pain and irritable bowel syndrome in children and adolescents.

Authors:  Eric Chiou; Samuel Nurko
Journal:  Therapy       Date:  2011-05-01

Review 7.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

8.  Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndrome.

Authors:  Arthur Beyder; Amelia Mazzone; Peter R Strege; David J Tester; Yuri A Saito; Cheryl E Bernard; Felicity T Enders; Weronica E Ek; Peter T Schmidt; Aldona Dlugosz; Greger Lindberg; Pontus Karling; Bodil Ohlsson; Maria Gazouli; Gerardo Nardone; Rosario Cuomo; Paolo Usai-Satta; Francesca Galeazzi; Matteo Neri; Piero Portincasa; Massimo Bellini; Giovanni Barbara; Michael Camilleri; G Richard Locke; Nicholas J Talley; Mauro D'Amato; Michael J Ackerman; Gianrico Farrugia
Journal:  Gastroenterology       Date:  2014-03-05       Impact factor: 22.682

9.  Identification of Individuals with Functional Dyspepsia With a Simple, Minimally Invasive Test: A Single Center Cohort Study of the Oral Capsaicin Test.

Authors:  Johann Hammer
Journal:  Am J Gastroenterol       Date:  2018-03-13       Impact factor: 10.864

Review 10.  Epigenetics and the developmental origins of inflammatory bowel diseases.

Authors:  Richard Kellermayer
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.